Nihon Chouzai Co (TSE:3341) Research & Development: 円0 Mil (TTM As of Sep. 2025)


TSE:3341 Nihon Chouzai Co Ltd TSE:3341
51 GF Score
Price 円3,925.00
GF Value 円1,563.20
! 10 Warning Signs
View Full Analysis

What is Nihon Chouzai Co Research & Development?

Nihon Chouzai Co TSE:3341 -0.13% 51 Research & Development is 円0 Mil as of Sep. 2025. GuruFocus rates TSE:3341 with a GF Score™ of 51/100 and a GF Value™ of 円1,563.20. The stock has 10 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Nihon Chouzai Co's Research & Development for the three months ended in Sep. 2025 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 was 円0 Mil.

Nihon Chouzai Co  (TSE:3341) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nihon Chouzai Co Research & Development Related Terms

Nihon Chouzai Co Research & Development Historical Data

* Premium members only.

The historical data trend for Nihon Chouzai Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nihon Chouzai Co Research & Development Chart

Nihon Chouzai Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nihon Chouzai Co Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:3341
51GF Score
Nihon Chouzai Co Ltd TSE:3341
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nihon Chouzai Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Nihon Chouzai Co (TSE:3341) has a Research & Development of 円0 Mil as of Sep. 2025. Research and development expense is the total cost for research and development activities. View historical data on Nihon Chouzai Co and its competitors.
Is Nihon Chouzai Co's Research & Development too high?
Nihon Chouzai Co's current Research & Development is 円0 Mil. Overall, Nihon Chouzai Co has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Nihon Chouzai Co's Research & Development compare to competitors?
Nihon Chouzai Co's Research & Development of 円0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nihon Chouzai Co and its competitors. Nihon Chouzai Co's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nihon Chouzai Co stock overvalued right now?
Nihon Chouzai Co (TSE:3341) has a current Research & Development of 円0 Mil. The stock's GF Value™ is 円1,563.20, compared to a current price of 円3,925.00 — trading 151.1% above its estimated fair value. The current Research & Development is 円0 Mil. Nihon Chouzai Co's overall GF Score™ is 51/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nihon Chouzai Co (TSE:3341), the current Research & Development is 円0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nihon Chouzai Co (TSE:3341) Overvalued in 2026?

Based on GuruFocus' analysis, Nihon Chouzai Co stock appears to be overvalued. The current stock price of 円3,925.00 is trading 151.1% above its estimated GF Value™ of 円1,563.20.

Key valuation signals for TSE:3341:

  • Research & Development: 円0 Mil
  • GF Value™: 円1,563.20 vs. price of 円3,925.00 (151.1% above fair value)
  • GF Score™: 51/100 with 10 warning signs

No single metric tells the full story. See the TSE:3341 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nihon Chouzai Co Business Description

Address Sapporo Odori Nishi Front Park 8 floors 7-1, Tokyo, JPN
Nihon Chouzai Co Ltd operates in the pharmaceutical industry. The company is organized into segments: Pharmacy, Pharmaceutical Manufacturing and Sales, and Healthcare Staffing Services and operates mainly from Japan. Through its operating segments, the firm manages a chain of pharmacies nationwide, manufactures and sells generic drugs, and provides staffing services that are specialized in pharmacy.
51GF Score

Get the complete analysis for TSE:3341

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,925.00
Price
円1,563.20
GF Value